Current and Future Clinical Trials to treat Alzheimer’s Disease

We’ll explore the latest developments and future directions in Alzheimer’s disease research. We’ll cover exciting breakthroughs in disease-modifying therapies, including anti-amyloid monoclonal antibodies, and discuss new advancements in treatments aimed at improving cognition and behavior. We’ll also delve into emerging areas like precision medicine, combination therapies, and the growing role of biomarkers in early detection and trial design. Throughout the session, we’ll examine the challenges surrounding trial recruitment and diversity, while also highlighting the potential of cutting-edge technologies like AI and digital health tools to revolutionize Alzheimer’s research and patient care. By the end of the presentation, you’ll gain a deeper understanding of the current progress and upcoming opportunities in the fight against Alzheimer’s disease. Presenter - Henry Tran, MD, FACC, FACP [email protected] 1635 North George Mason Drive Suite 420 Arlington, VA 22205 571-749-5807